Which intracranial lesions would be suitable for 5-aminolevulenic acid-induced fluorescence-guided identification, localization, or resection? A prospective study of 114 consecutive intracranial lesions.
Eljamel
M Sam
MS
Department of Neurosurgery, Ninewells Hospital and Medical School, Dundee, Scotland.
D000622:Aminolevulinic Acid; D001932:Brain Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D017319:Photosensitizing Agents; D011446:Prospective Studies; D011859:Radiography; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence; D025321:Surgery, Computer-Assisted; D016896:Treatment Outcome
D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid